Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.
Galapagos NV (GLPG.xams) Profile
Galápagos NV (GLPG.xams) is a Belgian biotechnology and
pharmaceutical research company headquartered in Mechelen, Belgium. Galápagos NV, known as
Galapagos Genomics, engages in small molecule therapeutics focusing on discovering, developing,
and commercialising innovative modes of action and drugs. Galapagos has a workforce of more than
1,400 professionals and facilities in cities around Europe and the United States, including the
Netherlands, France, Germany, Italy, Spain, Switzerland, the United Kingdom and the United
States. The leading biopharmaceutical company focuses on transformative research and
development, introducing human gene sequences into a wide spectrum of human cell lines to alter
by one-for-one substitution with transgene proteins or to add gene sequences that are not found
within the loci of interest, using a technological platform based on adenoviruses and
knockin-knockout method. Galápagos NV stock (GLPG.xams) is listed on the Euronext, on the
Nasdaq, is traded as a BEL 20 (benchmark stock market index Euronext Brussels) and Amsterdam
Exchange Index (AEX) constituent. Galapagos Genomics has a €3.06B (EUR) market cap as of
November 2021 and €530.3M (EUR) in 2020 yearly group revenue. In December 2020, Gilead and
Galapagos announced the commercialisation and development agreement for their Filgotinib drug.
On August 30, Galápagos NV announced the planned retirement of its CEO Onno van de Stolpe who
holds the position since 1999.
Galapagos NV (GLPG.xams): Trade a Contract for Difference (CFD) on GLPG.xams and speculate on
the share price difference of the underlying asset.
CFD is a
financial contract that allows you to trade on the underlying asset value (share price) without
the need to purchase the actual stock. Investors are trading the difference in the value of
security between the opening and closing of the trade. You can either hold a long position (Buy)
or a short position (Sell). CFDs are considered short-term investments or trades, as CFDs tend
to be used within shorter timeframes.
Increase your ability
to profit in
all
market conditions
Leverage options up to 20:1
Real-time, transparent
share prices
Control, Functionality and deep liquidity
Full Market depth & see your orders in the queue
MT4, MT5, Webtrader & Iress with
superior client portal
Award winning support &
personal account managers
Low margins and competitive commission
+10,000 products on global stocks
across 4 continents
On long positions
No ownership of physical
shares necessary
By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.
Source - cache | Page ID - 522
Share CFD Trading FAQ
What is a Share CFD?
What is a Share CFD?
Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.
Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.
What is the difference between CFD and Shares?
What is the difference
between CFD and Shares?
Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.
While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.
What are the most traded share CFDs?
What are the most
traded share CFDs?
Supply and demand are the main two pillars of share price sharping. The economic situation of countries, in addition to geopolitical risks and instability, can undoubtedly affect trade, financial flow, and consequently the share CFDs prices. In such situations the stock market price fluctuations can be excessively strong, creating opportunities for traders to generate returns investing on the foreign exchange but also excessive risks.
Thus, some well-performing companies offer more opportunities to traders due to their stable, smooth, and less volatile share price movement in the markets. Some of the top traded share CFDs represent the trending industries.
Technology companies such as Tesla Inc, Apple, Microsoft, and Facebook are some of the trader’s favorite shares to trade according to Investing.com. While some of the biotech representatives that have entered the top traded list of the global markets are Moderna, Pfizer, and Johnson & Johnson.
What factors should I consider when trading Share CFDs?
What factors should I
consider when trading
Share CFDs?
The main two driving forces of the forex currency market‘s volatility are supply and demand, placing the share CFDs trading amongst the most distinct volatility performers in the markets.
The economic situation of countries and unions, in addition to geopolitical risks and instability, can undoubtedly affect trade, financial flow, and consequently the interest rate of currencies, economies, and companies. In such situations the stock market price fluctuations can be excessively strong, creating opportunities for traders to generate returns investing on the share CFDs.
For instance, the current global pandemic situation has resulted in traders’ interest turning towards pharmaceutical and biotech companies, delivery and transportation as well as streaming and production services.